Docosahexaenoic acid augments hypothermic neuroprotection in a neonatal rat asphyxia model

Neonatology

Volumn 104, Issue 1, 2013, Pages 71-78

  Berman, Deborah R ^a   Mozurkewich, Ellen ^a   Liu, Yiqing ^b   Shangguan, Yu ^b   Barks, John D ^b,d   Silverstein, Faye S ^b,c  

^a Department of Ob/Gyn   (United States)

^b Departments of Pediatrics   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Albumin; Docosahexaenoic acid; Hypothermia

Indexed keywords

ALBUMIN; DOCOSAHEXAENOIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAROTID ARTERY LIGATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; FOREFOOT; HISTOPATHOLOGY; HYPOXIC ISCHEMIC ENCEPHALOPATHY; INDUCED HYPOTHERMIA; NEUROPROTECTION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; RIGHT HEMISPHERE; SENSORIMOTOR FUNCTION; SENSORIMOTOR NEUROPATHY; ANIMAL CELL; ANIMAL TISSUE; BRAIN DAMAGE; HYPOTHERMIA; NEUROPATHOLOGY; PERINATAL ASPHYXIA;

ANIMALS; ANIMALS, NEWBORN; ASPHYXIA NEONATORUM; BRAIN; BRAIN DISEASES; COMBINED MODALITY THERAPY; DISEASE MODELS, ANIMAL; DOCOSAHEXAENOIC ACIDS; FEMALE; HAND STRENGTH; HYPOTHERMIA, INDUCED; HYPOXIA-ISCHEMIA, BRAIN; MALE; NEUROPROTECTIVE AGENTS; RATS; RATS, WISTAR;

ANIMALIA; RATTUS;

EID: 84879476088     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000351011     Document Type: Article

References (29)

1. Belayev L, Marcheselli VL, Khoutorova L, Rodriguez de Turco EB, Busto R, Ginsberg MD, Bazan NG: Docosahexaenoic acid complexed to albumin elicits high-grade ischemic neuroprotection. Stroke 2005; 36: 118-123.
2. Huang WL, King VR, Curran OE, Dyall SC, Ward RE, Lal N, Priestly JV, Michael-Titus AT: A combination of intravenous and dietary docosahexaenoic acid significantly improves outcome after spinal cord injury. Brain 2007; 130: 3004-3019.
3. Pan H, Kao T, Ou Y, Yang DY, Yen YJ, Wang CC, Chuang YH, Liao SL, Raung SL, Wu CW, Chiang AN, Chen CJ: Protective effect of docosahexaenoic acid against brain injury in ischemic rats. J Nutr Biochem 2009; 20: 715-725.
4. Berman DR, Mozurkewich E, Liu Y, Barks J: Docosahexaenoic acid pretreatment confers neuroprotection in a rat model of perinatal cerebral hypoxia-ischemia. Am J Obstet Gynecol 2009; 200: 305.e1-e6.
5. Berman DR, Liu Y, Barks J, Mozurkewich E: Treatment with docosahexaenoic acid after hypoxia-ischemia improves forepaw placing in a rat model of perinatal hypoxia-ischemia. Am J Obstet Gynecol 2010; 203: 385.e1-e5.
6. Suganuma H, Arai Y, Kitamura Y, Hayashi M, Okumura A, Shimizu T: Maternal docosahexaenoic acid-enriched diet prevents neonatal brain injury. Neuropathology 2010; 30: 597-605.
7. Zhang W, Hu X, Yang W, Gao Y, Chen J: Omega-3 polyunsaturated fatty acid supplementation confers long-term neuroprotection against neonatal hypoxic-ischemic brain injury through anti-inflammatory actions. Stroke 2010; 41: 2341-2347.
8. Marcheselli V, Hong S, Lukiw W, Tian XH, Gronert K, Musto A, Hardy M, Gimenez JM, Chiang N, Serhan CN, Bazan NG: Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and proinflammatory gene expression. J Biol Chem 2003; 278: 43807-43817.
9. Bazan NG: Neuroprotectin D1-mediated anti-inflammatory and survival signaling in stroke, retinal degenerations and Alzheimer's disease. J Lipid Res 2009; 50(suppl):S400-S405.
10. Edwards AD, Brocklehurst P, Gunn AJ, Halliday H, Juszczak E, Levene M, Strohm B, Thoresen M, Whitelaw, A, Azzopardi D: Neurological outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic ischaemic encephalopathy: synthesis and meta-analysis of trial data. BMJ 2010; 340: c363.
11. Cilio MR, Ferriero DM: Synergistic neuroprotective therapies with hypothermia. Semin Fetal Neonat Med 2010; 15: 293-298.
12. Liu YQ, Barks JD, Xu G, Silverstein FS: Topiramate extends the therapeutic window for hypothermia-mediated neuroprotection after stroke in neonatal rats. Stroke 2004; 35: 1460-1465.
13. Barks JD, Liu YQ, Shangguan Y, Silverstein FS: Phenobarbital augments hypothermic neuroprotection. Pediatr Res 2010; 67: 532-537.
14. Liu Y, Shangguan Y, Barks JD, Silverstein FS: Bumetanide augments the neuroprotective efficacy of phenobarbital plus hypothermia in a neonatal hypoxia-ischemia model. Pediatr Res 2012; 71: 559-565.
15. Rice JE, Vannucci RC, Brierley JB: The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol 1981; 9: 131-141.
16. Grow JL, Liu YQ, Barks JD: Can lateralizing sensorimotor deficits be identified after neonatal cerebral hypoxia-ischemia in rats? Dev Neurosci 2003; 25: 394-402.
17. Pazaiti A, Soubasi V, Spandou E, Karkavelas G, Georgiou T, Karalis P, Guiba-Tziampiri: Evaluation of long-lasting sensorimotor consequences following neonatal hypoxic-ischemic brain injury in rats: the neuroprotective role of MgSO4. Neonatology 2009; 95: 33-40.
18. Schallert T, Fleming SM, Leasure JL, Tillerson JL, Bland ST: CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology 2000; 39: 777-787.
19. Trescher WH, Ishiwa S, Johnston MV: Brief post-hypoxic-ischemic hypothermia markedly delays neonatal brain injury. Brain Dev 1997; 19: 326-338.
20. Yang Y, Pan HC, Yen YJ, Wang CC, Chuang YH, Chen SY, Lin SY, Liao SL, Raung SL, Wu CW, Chou MC, Chiang AN, Chen CJ: Detrimental effects of post-treatment with fatty acids on brain injury in ischemic rats. Neurotoxicology 2007; 28: 1220-1229.
21. Alva N, Carbonell T, Palomeque J: Hypothermic protection in an acute hypoxia model in rats: acid-base and oxidant/antioxidant profiles. Resuscitation 2010; 81; 609-616.
22. Roberts LJ, Montine TJ, Markesbery WR, Tapper AR, Hardy P, Chemtob S, Dettbarn WD, Morrow JD: Formation of isoprostanelike compounds (neuroprostanes) in vivo from docosahexaenoic acid. J Biol Chem 1998; 273: 13605-13612.
23. Signorini C, Ciccoli L, Leoncini S, Carloni S, Perrone S, Comporti M, Balduini M, Buonocore G: Free iron, total F-isoprostanes and total F-neuroprostanes in a model of neonatal hypoxic-ischemic encephalopathy: neuroprotective effect of melatonin. J Pineal Res 2009; 46: 148-154.
24. D'Cruz BJ, Fertig KC, Filiano AJ, Hicks SD, DeFranco DB, Callaway CW: Hypothermic reperfusion after cardiac arrest augments brain-derived neurotrophic factor activation. J Cereb Blood Flow Metab 2002; 22: 843-851.
25. Wu A, Ying Z, Gomez-Pinilla F: Docosahexaenoic acid dietary supplementation enhances the effects of exercise on synaptic plasticity and cognition. Neuroscience 2008; 155: 751-759.
26. He C, Qu X, Cui L, Wang J, Kang JX: Improved spatial learning performance of fat-1 mice is associated with enhanced neurogenesis and neuritogenesis by docosahexaenoic acid. Proc Natl Acad Sci USA 2009; 106: 11370-11375.
27. Xiong M, Cheng GQ, Ma SM, Yang Y, Shao XM, Zhou WH: Post-ischemic hypothermia promotes generation of neural cells and reduces apoptosis by Bcl-2 in the striatum of neonatal rat brain. Neurochem Int 2011; 58: 625-633.
28. Hubbard WK: United States Food and Drug Administration. Letter responding to health claim petition dated November 3, 2003 (Martek petition): Omega-3 fatty acids and reduced risk of coronary heart disease (docket No. 2003Q-0401). Date of issue September 8, 2004. http://www.fda.gov/Food/LabelingNutrition/ LabelClaims/QualifiedHealthClaims/ucm072932.htm (accessed September 30, 2011).
29. Diamond IR, Sterescu A, Pencharz PB, Kim JH, Wales PW: Changing the paradigm: omegaven for the treatment of liver failure in pediatric short bowel syndrome. J Pediatr Gastroenterol Nutr 2009; 48: 209-215. Research Resources